Connor, Clark & Lunn Investment Management Ltd. Aura Biosciences, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$21.1 Billion
Q1 2025

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$8.11 - $11.74 $235,084 - $340,307	-28,987 Reduced 61.22%	18,364 $150,000
Q3 2024 Nov 08, 2024	SELL	$6.9 - $10.36 $80,757 - $121,253	-11,704 Reduced 19.82%	47,351 $421,000
Q2 2024 Aug 09, 2024	SELL	$6.81 - $7.89 $86,017 - $99,658	-12,631 Reduced 17.62%	59,055 $446,000
Q1 2024 May 09, 2024	BUY	$7.09 - $9.24 $416,636 - $542,979	58,764 Added 454.76%	71,686 $562,000
Q4 2023 Feb 09, 2024	BUY	$7.02 - $11.98 $90,712 - $154,805	12,922 New	12,922 $114,000

Others Institutions Holding AURA

# of Institutions

Shares Held

40.3M

Call Options Held

Put Options Held

6.4K

Matrix Capital Management Company, LP Waltham, MA

6.92M
Shares

$48.9 Million
12.68% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

4.88M
Shares

$34.5 Million
0.06% of portfolio
Long Focus Capital Management, LLC San Juan, PR

3.32M
Shares

$23.4 Million
0.67% of portfolio
Medicxi Ventures Management (Jersey) LTD

3.04M
Shares

$21.5 Million
5.39% of portfolio
Black Rock Inc. New York, NY

3.01M
Shares

$21.2 Million
0.0% of portfolio

View Full List

About Aura Biosciences, Inc.

Ticker AURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,273,600
Market Cap $207M
Description
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...

More about AURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account